|
1
|
Schaller MD, Borgman CA, Cobb BS, Vines
RR, Reynolds AB and Parsons JT: pp125FAK a structurally distinctive
protein-tyrosine kinase associated with focal adhesions. Proc Natl
Acad Sci USA. 89:5192–5196. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Nimwegen: MJ and van deW ater B: Focal
adhesion kinase: A potential target in cancer therapy. Biochem
Pharmacol. 73:597–609. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Megison ML, Stewart JE, Nabers HC, Gillory
LA and Beierle EA: FAK inhibition decreases cell invasion,
migration and metastasis in MYCN amplified neuroblastoma. Clin Exp
Metastasis. 30:555–568. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schlaepfer DD, Mitra SK and Ilic D:
Control of motile and invasive cell phenotypes by focal adhesion
kinase. Biochim Biophys Acta. 1692:77–102. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schaller MD: Biochemical signals and
biological responses elicited by the focal adhesion kinase. Biochim
Biophys Acta. 1540:1–21. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oktay MH, Oktay K, Hamele-Bena D, Buyuk A
and Koss LG: Focal adhesion kinase as a marker of malignant
phenotype in breast and cervical carcinomas. Hum Pathol.
34:240–245. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Watermann DO, Gabriel B, Jäger M,
Orlowska-Volk M, Hasenburg A, Hausen Zur A, Gitsch G and Stickeler
E: Specific induction of pp125 focal adhesion kinase in human
breast cancer. Br J Cancer. 93:694–698. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rovin JD, Frierson HF Jr, Ledinh W,
Parsons JT and Adams RB: Expression of focal adhesion kinase in
normal and pathologic human prostate tissues. Prostate. 53:124–132.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schneider GB, Kurago Z, Zaharias R, Gruman
LM, Schaller MD and Hendrix MJ: Elevated focal adhesion kinase
expression facilitates oral tumor cell invasion. Cancer.
95:2508–2515. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Judson PL, He X, Cance WG and Van Le L:
Overexpression of focal adhesion kinase, a protein tyrosine kinase,
in ovarian carcinoma. Cancer. 86:1551–1556. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim SJ, Park JW, Yoon JS, et al: Increased
expression of focal adhesion kinase in thyroid cancer:
Immunohistochemical study. J Korean Med Sci. 19:710–715. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fujii T, Koshikawa K, Nomoto S, Okochi O,
Kaneko T, Inoue S, Yatabe Y, Takeda S and Nakao A: Focal adhesion
kinase is overexpressed in hepatocellular carcinoma and can be
served as an independent prognostic factor. J Hepatol. 41:104–111.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lark AL, Livasy CA, Calvo B, Caskey L,
Moore DT, Yang X and Cance WG: Overexpression of focal adhesion
kinase in primary colorectal carcinomas and colorectal liver
metastases, Immunohistochemistry and real-time PCR analyses. Clin
Cancer Res. 9:215–222. 2003.PubMed/NCBI
|
|
14
|
Cance WG, Harris JE, Iacocca MV, et al:
Immunohistochemical analyses of focal adhesion kinase expression in
benign and malignant human breast and colon tissues: Correlation
with preinvasive and invasive phenotypes. Clin Cancer Res.
6:2417–2423. 2000.PubMed/NCBI
|
|
15
|
Miyazaki T, Kato H, Nakajima M, Sohda M,
Fukai Y, Masuda N, Manda R, Fukuchi M, Tsukada K and Kuwano H: FAK
overexpression is correlated with tumour invasiveness and lymph
node metastasis in oesophageal squamous cell carcinoma. Br J
Cancer. 89:140–145. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murata T, Naomoto Y, Yamatsuji T, et al:
Localization of FAK is related with colorectal carcinogenesis. Int
J Oncol. 32:791–796. 2008.PubMed/NCBI
|
|
17
|
Matkowskyj KA, Keller K, Glover S,
Kornberg L, Tran-Son-Tay R and Benya RV: Expression of GRP and its
receptor in well-differentiated colon cancer cells correlates with
the presence of focal adhesion kinase phosphorylated at tyrosines
397 and 407. J Histochem Cytochem. 51:1041–1048. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Owen JD, Ruest PJ, Fry DW and Hanks SK:
Induced focal adhesion kinase (FAK) expression in FAK-null cells
enhances cell spreading and migration requiring both auto- and
activation loop phosphorylation sites and inhibits
adhesion-dependent tyrosine phosphorylation of Pyk2. Mol Cell Biol.
19:4806–4818. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cary LA, Chang JF and Guan JL: Stimulation
of cell migration by overexpression of focal adhesion kinase and
its association with Src and Fyn. J Cell Sci. 109:1787–1794.
1996.PubMed/NCBI
|
|
20
|
Richardson A, Malik RK, Hildebrand JD and
Parsons JT: Inhibition of cell spreading by expression of the
C-terminal domain of focal adhesion kinase (FAK) is rescued by
coexpression of Src or catalytically inactive FAK, A role for
paxillin tyrosine phosphorylation. Mol Cell Biol. 17:6906–6914.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fan DM and Shi HR: Pilot study: Alteration
of deleted in liver cancer 1 and phosphorylated focal adhesion
kinase Y397 cytoplasmic expression and the prognostic value in
advanced epithelial ovarian carcinoma. Int J Mol Sci. 12:8489–8501.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Madan R, Smolkin MB, Cocker R, Fayyad R
and Oktay MH: Focal adhesion proteins as markers of malignant
transformation and prognostic indicators in breast carcinoma. Hum
Pathol. 37:9–15. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lai IR, Chu PY, Lin HS, Liou JY, Jan YJ,
Lee JC and Shen TL: Phosphorylation of focal adhesion kinase at
Tyr397 in gastric carcinomas and its clinical significance. Am J
Pathol. 177:1629–1637. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lark AL, Livasy CA, Dressler L, et al:
High focal adhesion kinase expression in invasive breast carcinomas
is associated with an aggressive phenotype. Mod Pathol.
18:1289–1294. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lightfoot HM Jr, Lark A, Livasy CA, Moore
DT, Cowan D, Dressler L, Craven RJ and Cance WG: Upregulation of
focal adhesion kinase (FAK) expression in ductal carcinoma in situ
(DCIS) is an early event in breast tumorigenesis. Breast Cancer Res
Treat. 88:109–116. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Corsi JM, Houbron C, Billuart P, et al:
Autophosphorylation-independent and-dependent functions of focal
adhesion kinase during development. J Biol Chem. 284:34769–34776.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Grisaru-Granovsky S, Salah Z, Maoz M,
Pruss D, Beller U and Bar-Shavit R: Differential expression of
protease activated receptor 1 (Par1) and pY397FAK in benign and
malignant human ovarian tissue samples. Int J Cancer. 113:372–378.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aronsohn MS, Brown HM, Hauptman G and
Kornberg LJ: Expression of focal adhesion kinase and phosphorylated
focal adhesion kinase in squamous cell carcinoma of the larynx.
Laryngoscope. 113:1944–1948. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Carelli S, Zadra G, Vaira V, et al:
Up-regulation of focal adhesion kinase in non-small cell lung
cancer. Lung Cancer. 53:263–271. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kurio N, Shimo T, Fukazawa T, Takaoka M,
Okui T, Hassan NM, Honami T, Hatakeyama S, Ikeda M, Naomoto Y, et
al: Anti-tumor effect in human breast cancer by TAE226, a dual
inhibitor for FAK and IGF-IR in vitro and in vivo. Exp Cell Res.
317:1134–1146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kurio N, Shimo T, Fukazawa T, et al:
Anti-tumor effect of a novel FAK inhibitor TAE226 against human
oral squamous cell carcinoma. Oral Oncol. 48:1159–1170. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Slack JK, Adams RB, Rovin JD, Bissonette
EA, Stoker CE and Parsons JT: Alterations in the focal adhesion
kinase/Src signal transduction pathway correlate with increased
migratory capacity of prostate carcinoma cells. Oncogene.
20:1152–1163. 2001. View Article : Google Scholar : PubMed/NCBI
|
